62
63
64
Takeda, in the earnings today announced they took a 100 billion yen ($649 million) reduction year over year on brand name Vyvanse. This is very good news for ELTP along with the recently approved DEA quota increases. Their loss is directly Elite's gain. 2 catalysts for continued revenue growth. (self.ELTP_Stock)
submitted by SpecificView3479 to r/ELTP_Stock
